AzTrials
AzTrials

Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)INCLUDENCT03131505

INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1

An observational study of Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) and Schizophrenia, run by Norfolk and Suffolk NHS Foundation Trust at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The focus of this study is not about what it is like to have a mental disorder, but instead the diagnostic experience. Some people find diagnoses helpful, but some find them upsetting and harmful. Research is therefore needed to improve diagnostic processes. Read more about this study

Who is it for?
Ages 18 years and older
How many people
59 participants
Where
1 siteUnited Kingdom
Study dates
22 Feb 2017to 21 Feb 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Mental health service users clinicians

Who may be able to join

  • Adult service users will have formally received one of the five diagnoses under investigation: Unipolar Depression, Schizophrenia, Bipolar Disorder, Generalised Anxiety Disorder or Personality Disorder.
  • Clinicians will have had experience working with mental health, either as a GP or psychiatrist, where diagnosing any of the above diagnoses is part of their role.
  • Carers will have had experience looking after someone with the above diagnoses.
  • Service users with multiple diagnoses will be allowed to participate, and choose which one of the relevant focus groups they would like to attend.
  • Service users will be under the care of an NSFT service.

Who cannot join

  • Individuals under 18 years old.
  • Individuals who do not have capacity to give consent.
  • Individuals who lose capacity during the study.
  • Individuals who do not speak English.
  • Individuals will be excluded if their participation is deemed unsafe to themselves or others by their lead clinician or clinicians on the research team.
  • Individuals who have taken part in another group or part of the study.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Norfolk and Suffolk NHS Foundation Trust

    Norwich, NR6 5BE

Other trials in United Kingdom

About this study

Official title: Perspectives on the INternational CLassification of Diseases (11th Revision); Using Lived Experience to Improve Mental Health Diagnosis in NHS England: INCLUDE Study

The focus of this study is not about what it is like to have a mental disorder, but instead the diagnostic experience.

Some people find diagnoses helpful, but some find them upsetting and harmful. Research is therefore needed to improve diagnostic processes. It has been suggested that patient experiences and outcomes may be affected by the diagnostic tools used, including diagnostic criteria, labels and language. In the NHS, the tool used by doctors to help diagnose people is a guidebook called the International Classification of Diseases (ICD). A new version of this guide is due to be released in 2018.

This project will use focus groups to ask people who use mental health services and diagnosing doctors in those services what they think about the labels and language in the new guide. The investigators can then suggest changes before the guide is published. The investigators hope that this research will improve mental health diagnosis. The research will take place in Norfolk and Suffolk and span eight months.

Read the detailed description

This is a qualitative project requested by the World Health Organisation (WHO), and planned by Norfolk and Suffolk NHS Foundation Trust and the University of East Anglia. The research aims and design have been developed in consultation with service users, clinicians, academics and the World Health Organisation (WHO). These groups have told the investigators that mental health diagnosis can have unintended, negative consequences. This is supported by a large body of existing research. It has been suggested that patient experiences and outcomes may be affected by the diagnostic classifications used (i.e. labels and language). The investigators plan to explore service users' and clinicians' views on the proposed ICD-11 diagnostic classifications. To do this, the investigators will provide participants with the proposed ICD-11 diagnostic classification relevant to their experience, and conduct focus groups to explore people's views of the new diagnostic classifications, including judgement about the clinical accuracy, the language used, what people think is helpful and unhelpful, and what could be improved. The topic guide for the focus groups will be developed in consultation with the advisory group (comprising service users, carers and clinicians).

The investigators will conduct separate focus groups for service users and clinicians as the investigators believe joint groups may impact the findings. The investigators will collate findings to produce recommendations for the criteria and language proposed for ICD-11. These recommendations will be discussed in feedback groups of service users, carers and clinicians, which will provide further participants an opportunity for additional thoughts and reflection.

Inclusion

  • Adult service users will have formally received one of the five diagnoses under investigation: Unipolar Depression,Schizophrenia, Bipolar Disorder, Generalised Anxiety Disorder or Personality Disorder.
  • Individuals will be excluded if their participation is deemed unsafe to themselves or others by their clinical team or clinicians on the research team.
  • Clinicians will have had experience working with mental health, either as a GP or psychiatrist, where diagnosing one of the above five diagnoses is part of their role.
  • Carers will have had experience looking after someone diagnosed with one of the five diagnoses mentioned above.
  • Participants who have been involved in one aspect of the study will be excluded from taking part in any other aspects (e.g. participants in the focus group may not be involved in other focus or feedback groups).
  • Participants with multiple diagnoses will only be allowed to attend one focus group, but they may choose which one of the relevant focus groups they would like to take part in.

Exclusion:

  • Non-English speakers will not be included in the study.
  • Individuals under 18 years old will be excluded.
  • Individuals who do not have capacity to give consent will be excluded. Individuals who lose capacity at any point between referral and the end of their participation will be removed from the study.
Medical subject headings
Depression, Psychotic Disorders, Personality Disorders, Substance-Related Disorders, Schizophrenia, Generalized Anxiety Disorder, Bipolar Disorder

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Qualitative evaluation of the impact of new ICD-11 diagnostic criteria via focus groups with people living with mental health conditions and clinicians.

    Focus groups will be undertaken with people who have received a mental health diagnosis (unipolar or bipolar depression, generalised anxiety disorder, schizophrenia, personality disorder) and clinicians working in mental health services. The focus groups will follow a structured topic guide, based around the new diagnostic criteria and language for each condition to understand participants' views on meaning, accessibility, stigma and recovery

    Measured: 8 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Apr 2017
  2. Study start22 Feb 2017
  3. Primary completion1 Dec 2017
  4. Study completion21 Feb 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
59 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03131505
Sponsor's protocol ID
216352
Acronym
INCLUDE
Status last verified
Mar 2018
First submitted
20 Apr 2017
Last updated
29 Mar 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hackmann C, Green A, Notley C, Perkins A, Reed GM, Ridler J, Wilson J, Shakespeare T. Protocol for a qualitative study exploring perspectives on the INternational CLassification of Diseases (11th revision); Using lived experience to improve mental health Diagnosis in NHS England: INCLUDE study. BMJ Open. 2017 Sep 3;7(9):e018399. doi: 10.1136/bmjopen-2017-018399.

    PubMed 28871029

Questions about this trial

What is this clinical trial studying?

An observational study of Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) and Schizophrenia, run by Norfolk and Suffolk NHS Foundation Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Qualitative evaluation of the impact of new ICD-11 diagnostic criteria via focus groups with people living with mental health conditions and clinicians. (time frame: 8 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03131505, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Mar 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in